Skip to main content
. 2021 Jun;9(12):1033. doi: 10.21037/atm-20-8124

Table 4. AD exacerbation during ICI therapy.

Characteristic Patients (n)
Flare of underlying AD
   1. Patients who did not develop AD flare 30
   2. Patients who developed AD flare 12
Grades of AD flares
   1. Grade 1–2 7
   2. Grade 3–4 3
   3. Grade unknown 2
Treatment required for AD flares
   1. No treatment required/supportive care 1
   2. Corticosteroids only 8
   3. Tofacitinib 1
   4. Infliximab 1
   5. Plasmapheresis 1
ICI therapy during/after AD flare
   • Continued 7
   • Permanently discontinued 5

AD, autoimmune disease; ICI, Immune check point inhibitor.